179 results on '"Juday, Timothy"'
Search Results
2. Fall Risk, Healthcare Resource Use, and Costs Among Adult Patients in the United States Treated for Insomnia with Zolpidem, Trazodone, or Benzodiazepines: A Retrospective Cohort Study
3. Development of a triage algorithm for mild cognitive impairment using electronic health record data
4. Retrospective cohort study comparing risk of falls and associated incremental costs among adults treated with specific insomnia medications
5. Trazodone in the off-label treatment of insomnia: Abuse and safety risks
6. Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice
7. Lemborexant and Daridorexant for the Treatment of Insomnia
8. Economic burden of comorbid insomnia in 5 common medical disease subgroups
9. Benzodiazepine Usage, Healthcare Resource Utilization, and Costs Among Older Adults Treated with Common Insomnia Medications: A Retrospective Cohort Study
10. Lemborexant and Daridorexant for the Treatment of Insomnia: An Indirect Comparison, Using Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
11. Incremental health care resource use and costs among adult patients with depression and treated for insomnia with zolpidem, trazodone, or benzodiazepines
12. Cardiac events and economic burden among patients with hypertension and treated insomnia in the USA
13. Burden of insomnia among cancer patients undergoing treatment: A retrospective claims database analysis.
14. Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States
15. Comparative Incidence and Health Care Costs of Medically Attended Adverse Effects among U.S. Medicaid HIV Patients on Atazanavir- or Darunavir-Based Antiretroviral Therapy
16. Patterns and Correlates of Linkage to Appropriate HIV Care After HIV Diagnosis in the US Medicaid Population
17. Additional file 1 of Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines
18. A School-Based Program to Improve Life Skills and to Prevent HIV Infection in Multicultural Transgendered Youth in Hawai'i
19. Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCV
20. Lemborexant for the Treatment of Insomnia
21. Adherence to Chronic Hepatitis B Treatment Guideline Recommendations for Laboratory Monitoring of Patients Who Are Not Receiving Antiviral Treatment
22. The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C: Results From an Analysis of Data From a Department of Veterans Affairs Clinical Registry
23. Assessing Lemborexant Efficacy and Safety in the Treatment of Insomnia
24. The Role of Medicaid HMO Enrollment in the Longitudinal Utilization of Medical Care Services in a Cohort of Injecting Drug Users in Baltimore, Maryland
25. Factors Associated with Complete Adherence to HIV Combination Antiretroviral Therapy
26. Challenges and opportunities in insomnia disorder
27. Costs, exacerbations and pneumonia after initiating combination tiotropium olodaterol versus triple therapy for chronic obstructive pulmonary disease
28. Challenges and opportunities in insomnia disorder.
29. IMPACT OF NON-MEDICAL SWITCHING OF ANTI-TUMOR NECROSIS FACTOR AGENTS ON HEALTHCARE COSTS IN EUROPE
30. Public health impact of comprehensive hepatitis C screening and treatment in the French baby-boomer population
31. Five Laboratory Tests Predict Patient Risk and Treatment Response in Hepatitis C: Veterans Affairs Data from 1999-2010
32. Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCV
33. The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir
34. The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV
35. Systematic Literature Review and Meta-Analysis of Renal Function in Human Immunodeficiency Virus (HIV)-Infected Patients Treated with Atazanavir (ATV)-Based Regimens
36. Comparative Value of Four Measures of Retention in Expert Care in Predicting Clinical Outcomes and Health Care Utilization in HIV Patients
37. Data-Driven Decision-Making Tools To Improve Public Resource Allocation For Care And Prevention Of HIV/AIDS
38. The Prospect Of A Generation Free Of HIV May Be Within Reach If The Right Policy Decisions Are Made
39. Early HIV Treatment In The United States Prevented Nearly 13,500 Infections Per Year During 1996–2009
40. HIV Care Providers Emphasize The Importance Of The Ryan White Program For Access To And Quality Of Care
41. Early HIV Treatment Led To Life Expectancy Gains Valued At $80 Billion For People Infected In 1996–2009
42. Nearly 60,000 Uninsured And Low-Income People With HIV/AIDS Live In States That Are Not Expanding Medicaid
43. Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA
44. Sa1006 Effectiveness of Oral Antiviral Therapy for Treatment-Naive Chronic Hepatitis B (CHB) in Routine Clinical Practice
45. Effect of Persistency of First-Line HIV Antiretroviral Therapy on Clinical Outcomes
46. Outcomes of Second Combination Antiretroviral Therapy Regimens Among HIV-Infected Persons in Clinical Care: A Multicenter Cohort Study
47. Cost-effectiveness of efavirenz vs rilpivirine in HIV patients initiating first-line combination antiretroviral therapy
48. The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV.
49. Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens
50. Adherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.